R. S. Ames, Y. Li, H. M. Sarau, P. Nuthulaganti, J. J. Foley et al., Molecular cloning and characterisation of the human anaphylatoxin C3a receptor, J. Biol. Chem, vol.271, pp.20231-20234, 1996.

W. P. Arend, R. J. Massoni, M. A. Nieman, and P. C. Giclas, Absence of induction of IL-1 production in human monocytes by complement fragments, J. Immunol, vol.142, pp.173-178, 1989.

S. C. Bischoff, A. L. Deweck, and C. A. Dahinden, Interleukin-3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a, Proc. Natl. Acad. Sci. USA, vol.87, pp.6813-6817, 1990.

D. Caput, B. Beutler, K. Hartog, R. Thayer, S. Brown-shimer et al., Identification of a common nucleotide sequence in the 3-untranslated region of mRNA molecules specifying inflammatory mediators, Proc. Natl. Acad. Sci. USA, vol.83, pp.1670-1674, 1986.

D. A. Compston, B. P. Morgan, A. K. Campbell, P. Wilkins, G. Dole et al., Immunocytochemical localisation of the terminal complement complex in multiple sclerosis, Neuropathol. Appl. Neurobiol, vol.15, pp.307-316, 1989.

T. Crass, U. Raffetseder, U. Martin, M. Grove, A. Klos et al., Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U937 cells, Eur. J. Immunol, vol.26, pp.1944-1950, 1996.

K. E. Foreman, A. A. Vaporciyan, B. K. Bonish, M. L. Jones, M. M. Glovsky et al., C5a-induced expression of P-selectin in endothelial cells, J. Clin. Invest, vol.94, pp.1147-1150, 1994.

M. M. Frank and L. F. Fries, Complement interactions and functions: the role of complement in inflammation and phagocytosis, Immunol. Today, vol.12, pp.322-326, 1991.

R. A. Gadient and U. H. Otten, Interleukin-6 (IL-6), a molecule with both beneficial and destructive potentials, Prog. Neurobiol, vol.52, pp.379-390, 1997.

P. Gasque, N. Julen, A. Ischenko, C. Picot, C. Mauger et al., Expression of complement components of the alternative pathway by glioma cell lines, J. Immunol, vol.149, pp.1381-1387, 1992.

P. Gasque, A. Ischenko, J. Legoedec, C. Mauger, M. T. Schouft et al., Expression of the complement classical pathway by human glioma in culture. A model for complement expression by nerve cells, J. Biol. Chem, vol.268, pp.25068-25074, 1993.

P. Gasque, P. Chan, M. Fontaine, A. Ischenko, M. Lamacz et al., Identification and characterisation of the complement C5a anaphylatoxin receptor on human astrocytes: relevance to inflammation in the brain, J. Immunol, vol.155, pp.4882-4889, 1995.

P. Gasque, M. Fontaine, and M. B. , Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines, J. Immunol, vol.154, pp.4726-4733, 1995.

P. Gasque, S. K. Singhrao, J. W. Neal, P. Wang, S. Sayah et al., The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis, J. Immunol, vol.160, pp.3543-3554, 1998.

N. P. Gerard and C. Gerard, The chemotactic receptor for C5a anaphylatoxin, Nature, vol.349, pp.614-617, 1991.

M. G. Goodman, D. E. Chenoweh, and W. O. Weigle, Induction of interleukin-1 secretion and enhancement of humoral immunity by binding of human C5a to macrophages surface C5a receptors, J. Exp. Med, vol.156, pp.912-917, 1982.

N. Haeffner-cavaillon, J. M. Cavaillon, M. Laude, and M. D. Kazatchkine, C3a (C3adesarg) induces production and release of interleukin-1 by cultured human monocytes, J. Immunol, vol.139, pp.794-799, 1987.

D. L. Haviland, R. L. Maccoy, W. T. Whitehead, H. Akama, E. P. Molmenti et al., Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung, J. Immunol, vol.154, pp.1861-1869, 1995.

A. M. Ischenko, S. Sayah, C. Patte, S. Andreev, P. Gasque et al., Expression of a functional anaphylatoxin C3a receptor by astrocytes, J. Neurochem, vol.71, pp.2487-2496, 1998.

S. A. Johnson, M. Lampert-etchells, G. M. Pasinetti, I. Rozovsky, and C. E. Finch, Complement mRNAs in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning, Neurobiol. Aging, vol.13, pp.641-648, 1992.

R. L. Kaspar and L. Gehrke, Peripheral blood mononuclear cells stimulated with C5a or lipopolysaccharide to synthesize equivalent levels of IL-1 mRNA show unequal IL-1 protein accumulation but similar polyribosome profiles, J. Immunol, vol.153, pp.277-286, 1994.

C. Linington, B. P. Morgan, N. J. Scolding, S. Piddlesden, P. Wilkins et al., The role of complement in the pathogenesis of experimental allergic encephalomyelitis, Brain, vol.112, pp.895-911, 1989.

Y. Maeda, M. Matsumoto, O. Hori, K. Kuwabara, S. Ogawa et al., , 1994.

, Hypoxia/reoxygenation-mediated induction of astrocyte interleukin-6: a paracrine mechanism potentially enhancing neuron survival, J. Exp. Med, vol.180, pp.2297-2308

D. Maimone, G. C. Guazzi, and P. Annunziata, IL-6 detection in multiple sclerosis brain, J. Neurol. Sci, vol.146, pp.59-65, 1996.

J. S. Malter, Identification of an AUUUA-specific messenger RNA binding protein, Science, vol.246, pp.664-668, 1989.

E. G. Mcgeer and P. L. Mcgeer, Inflammatory cytokines in the CNS. Possible role in the pathogenesis of neurodegenerative disorders and therapeutic implications, Pharmacol. Pathophysiol, vol.3, pp.214-228, 1997.

J. Norgauer, G. Dobos, E. Kownatzki, C. Dahinden, R. Burger et al., Complement fragment C3a stimulates Ca 2 influx in neutrophils via a pertussis-toxin sensitive G protein, Eur. J. Biochem, vol.217, pp.289-294, 1993.

G. M. Pasinetti, S. A. Johnson, I. Rozovski, M. Lampert-etchells, D. G. Morgan et al., Complement C1q and C4 mRNA responses to lesioning in rat brain, Exp. Neurol, vol.118, pp.117-125, 1992.

S. J. Piddlesden and B. P. Morgan, Killing rat glial cells by complement components: deficiency of the rat analogue CD59 is the cause of oligodendrocyte susceptibility to lysis, J. Neuroimmunol, vol.48, pp.169-176, 1993.

S. J. Piddlesden, M. K. Storch, M. Hibbs, A. M. Freeman, H. Lassman et al., Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis, J. Immunol, vol.152, pp.5477-5484, 1994.

J. Rogers, N. R. Cooper, S. Webster, J. Schultz, P. L. Mcgeer et al., Complement activation by -amyloid in Alzheimer disease, Proc. Natl. Acad. Sci. USA, vol.89, pp.10016-10020, 1992.

A. Roglic, E. R. Prossnitz, S. L. Cavanagh, Z. Pan, A. Zou et al., cDNA cloning of a novel G-protein-coupled receptor with a large extracellular loop structure, Biochim. Biophys. Acta, vol.1305, pp.39-43, 1996.

T. E. Rollins, S. Siciliano, S. Kobayashi, D. N. Cianciarulo, V. Bonillaargudo et al., Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-G i complex, Proc. Natl. Acad. Sci. USA, vol.88, pp.971-975, 1991.

, mRNA INDUCTION BY ANAPHYLATOXINS ON ASTROCYTES, vol.72, issue.6, pp.2435-2441, 1999.

J. Sambrook, E. F. Fritsch, and M. T. , Molecular Cloning, A Laboratory Manual, vol.22, pp.7-19, 1989.

S. Sayah, C. Patte, P. Gasque, P. Chan, A. Ischenko et al., Characterisation of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes, Mol. Brain Res, vol.48, pp.215-222, 1997.

S. Sayah, P. Leon, P. Chan, and M. Fontaine, C3a and C5a anaphylatoxin receptors, Med. Sci, vol.14, pp.291-299, 1998.

R. Schindler, J. A. Gelfand, and C. A. Dinarello, Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1, Blood, vol.76, pp.1631-1638, 1990.

T. Takabayashi, E. Vannier, B. D. Clark, N. H. Margolis, C. A. Dinarello et al., A new biological role for C3a and C3a desarg. Regulation of TNF-and IL-1 synthesis, J. Immunol, vol.156, pp.3455-3460, 1996.

N. Tonouchi, K. Miwa, H. Karasuyama, and H. Matsui, Deletion of the 3-untranslated region of human BSF-2 mRNA causes stabilisation of the mRNA and high-level expression in mouse NIH-3T3 cells, Biochem. Biophys. Res. Commun, vol.163, pp.1056-1062, 1989.

D. G. Walker and P. L. Mcgeer, Complement gene expression in human brain: comparison between normal and Alzheimer disease cases, Mol. Brain Res, vol.14, pp.109-116, 1992.

T. Werfel, J. Zwirner, M. Opperman, A. Sieber, G. Begeman et al., CD88 antibodies specifically bind to C5aR on dermal CD117 and CD14 cells and react with a desmosomal antigen in human skin, J. Immunol, vol.157, pp.1729-1735, 1996.

D. R. Wren and M. Noble, Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody, Proc. Natl. Acad. Sci. USA, vol.86, pp.9025-9029, 1989.